A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/18/2004	WO2004099207A1 Microcrystal
11/18/2004	WO2004099133A1 2”-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098633A1 Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
11/18/2004	WO2004098632A1 Skin collagen production promoter
11/18/2004	WO2004098603A1 Use of substituted aminoalkanephosphonic acids in the treatment of multiple sclerosis
11/18/2004	WO2004098598A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004098597A1 Composition comprising roflumilast and shuil-1r ii
11/18/2004	WO2004098595A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004	US20040229946 Antidiabetic agents
11/18/2004	US20040229944 Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229886 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229879 CRF receptor antagonists and methods relating thereto
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229857 Neurotherapeutic composition and method
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229843 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229804 Tribonectins
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040228903 Soft drink replacer
11/18/2004	US20040228889 Use of N-arylmethylene ethylenediaminetriacetates, N-arylmethylene iminodiacetated or N,N'-diarylmethylene ethylenediamineacetates as doners of NO
11/18/2004	US20040228876 Composition and Method for Treating Cancer Using Herpes Virus
11/18/2004	US20040228875 comprises taurine, floridoside, carotenoids and polyunsaturated fatty acids, water-soluble vitamins, amino acids, and pigments; induces synthesis of stress protective proteins; for protecting skin against wrinkle formation/inflammation
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
11/18/2004	US20040228806 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles
11/18/2004	DE102004014929A1 Methoden und Rezepturen zur Hemmung der natürlich vorkommenden Phosphodiesterase Methods and formulations for inhibiting naturally occurring phosphodiesterase
11/18/2004	CA2523242A1 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity
11/17/2004	EP1477490A1 Pyrrolopyrimidine derivative
11/17/2004	EP1477489A1 Pyrrolopyrimidine derivatives
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477479A1 Process for the preparation of the D-(-)-tartrate salt of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanol
11/17/2004	EP1477472A1 Substituted phenylalkanoic acid derivative and use thereof
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1477182A1 Novel analgesics
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1477179A1 Anion exchange resin adsorbed fraction, immunopotentiator and promoter for recovery from loaded stress originating in matsutake mushroom
11/17/2004	EP1477177A1 Process for producing hydrophobic glycyrrhiza extract with high qualities
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476457A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SiNA)
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476444A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476200A2 Compositions and method for regulation of calcium-dependent signalling in brain
11/17/2004	EP1476187A2 Methods of extending corneal graft survival
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476179A2 Methods of preventing or treating brain ischemia or brain injury
11/17/2004	EP1476169A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1476150A2 Carboxyfullerenes and methods of use thereof
11/17/2004	EP1476149A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
11/17/2004	EP1476148A2 Partial dopamine-d2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
11/17/2004	EP1476146A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476131A2 Compositions and methods for delivery of skin cosmeceuticals

1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1564